MRGPRX2 is negatively targeted by SCF and IL‐4 to diminish pseudo‐allergic stimulation of skin mast cells in culture

MRGPRX2 was recently uncovered as the “missing link” in clinically relevant mast cell (MC) activation explaining previously puzzling phenomena. It is the receptor for various endogenous ligands and exogenous compounds alike, whose binding evokes rapid degranulation much like allergen‐mediated exocyt...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Experimental dermatology Ročník 27; číslo 11; s. 1298 - 1303
Hlavní autoři: Babina, Magda, Wang, Zhao, Artuc, Metin, Guhl, Sven, Zuberbier, Torsten
Médium: Journal Article
Jazyk:angličtina
Vydáno: Denmark Wiley Subscription Services, Inc 01.11.2018
Témata:
Allergens
allergy
Cell activation
Cell culture
Degranulation
Exocytosis
Hypersensitivity
Mast cells
MRGPRX2
pseudo‐allergy
SCF
Skin
allergy
pseudo-allergy
mast cells
MRGPRX2
SCF
ISSN:0906-6705, 1600-0625, 1600-0625
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract MRGPRX2 was recently uncovered as the “missing link” in clinically relevant mast cell (MC) activation explaining previously puzzling phenomena. It is the receptor for various endogenous ligands and exogenous compounds alike, whose binding evokes rapid degranulation much like allergen‐mediated exocytosis. While the perceivable outcomes are similar, the two activation routes differ regarding mechanism and regulation. We recently reported that acute SCF administration curbs responses evoked by MRGPRX2 in human skin MCs. Maintenance of MCs in culture requires the presence of MC supportive factors and renders the cells functionally and molecularly unequal to ex vivo counterparts. Here, we asked whether expansion in culture impacts the pseudo‐allergic route, and if so, what contribution SCF and IL‐4 play in this scenario. We report that the in vitro micromilieu dampens (but does not erase) pseudo‐allergic responses and that this is accompanied by strongly reduced MRGPRX2 expression. Withdrawal of SCF or IL‐4 individually, but most potently of both collectively, partially reinstates the MRGPRX2 pathway, revealing that SCF and IL‐4 make negative adjustments to the pseudo‐allergic pathway. Under all conditions, the FcεRI‐triggered route showed the inverse pattern of regulation, substantiating that allergic and pseudo‐allergic MC activation can obey opposite rules, hinting at possible competition between them.
AbstractList MRGPRX2 was recently uncovered as the "missing link" in clinically relevant mast cell (MC) activation explaining previously puzzling phenomena. It is the receptor for various endogenous ligands and exogenous compounds alike, whose binding evokes rapid degranulation much like allergen-mediated exocytosis. While the perceivable outcomes are similar, the two activation routes differ regarding mechanism and regulation. We recently reported that acute SCF administration curbs responses evoked by MRGPRX2 in human skin MCs. Maintenance of MCs in culture requires the presence of MC supportive factors and renders the cells functionally and molecularly unequal to ex vivo counterparts. Here, we asked whether expansion in culture impacts the pseudo-allergic route, and if so, what contribution SCF and IL-4 play in this scenario. We report that the in vitro micromilieu dampens (but does not erase) pseudo-allergic responses and that this is accompanied by strongly reduced MRGPRX2 expression. Withdrawal of SCF or IL-4 individually, but most potently of both collectively, partially reinstates the MRGPRX2 pathway, revealing that SCF and IL-4 make negative adjustments to the pseudo-allergic pathway. Under all conditions, the FcεRI-triggered route showed the inverse pattern of regulation, substantiating that allergic and pseudo-allergic MC activation can obey opposite rules, hinting at possible competition between them.
MRGPRX2 was recently uncovered as the "missing link" in clinically relevant mast cell (MC) activation explaining previously puzzling phenomena. It is the receptor for various endogenous ligands and exogenous compounds alike, whose binding evokes rapid degranulation much like allergen-mediated exocytosis. While the perceivable outcomes are similar, the two activation routes differ regarding mechanism and regulation. We recently reported that acute SCF administration curbs responses evoked by MRGPRX2 in human skin MCs. Maintenance of MCs in culture requires the presence of MC supportive factors and renders the cells functionally and molecularly unequal to ex vivo counterparts. Here, we asked whether expansion in culture impacts the pseudo-allergic route, and if so, what contribution SCF and IL-4 play in this scenario. We report that the in vitro micromilieu dampens (but does not erase) pseudo-allergic responses and that this is accompanied by strongly reduced MRGPRX2 expression. Withdrawal of SCF or IL-4 individually, but most potently of both collectively, partially reinstates the MRGPRX2 pathway, revealing that SCF and IL-4 make negative adjustments to the pseudo-allergic pathway. Under all conditions, the FcεRI-triggered route showed the inverse pattern of regulation, substantiating that allergic and pseudo-allergic MC activation can obey opposite rules, hinting at possible competition between them.MRGPRX2 was recently uncovered as the "missing link" in clinically relevant mast cell (MC) activation explaining previously puzzling phenomena. It is the receptor for various endogenous ligands and exogenous compounds alike, whose binding evokes rapid degranulation much like allergen-mediated exocytosis. While the perceivable outcomes are similar, the two activation routes differ regarding mechanism and regulation. We recently reported that acute SCF administration curbs responses evoked by MRGPRX2 in human skin MCs. Maintenance of MCs in culture requires the presence of MC supportive factors and renders the cells functionally and molecularly unequal to ex vivo counterparts. Here, we asked whether expansion in culture impacts the pseudo-allergic route, and if so, what contribution SCF and IL-4 play in this scenario. We report that the in vitro micromilieu dampens (but does not erase) pseudo-allergic responses and that this is accompanied by strongly reduced MRGPRX2 expression. Withdrawal of SCF or IL-4 individually, but most potently of both collectively, partially reinstates the MRGPRX2 pathway, revealing that SCF and IL-4 make negative adjustments to the pseudo-allergic pathway. Under all conditions, the FcεRI-triggered route showed the inverse pattern of regulation, substantiating that allergic and pseudo-allergic MC activation can obey opposite rules, hinting at possible competition between them.
Author Artuc, Metin
Guhl, Sven
Wang, Zhao
Zuberbier, Torsten
Babina, Magda
Author_xml – sequence: 1
  givenname: Magda
  orcidid: 0000-0002-4500-7615
  surname: Babina
  fullname: Babina, Magda
  email: magda.babina@charite.de
  organization: Berlin Institute of Health
– sequence: 2
  givenname: Zhao
  surname: Wang
  fullname: Wang, Zhao
  organization: Berlin Institute of Health
– sequence: 3
  givenname: Metin
  surname: Artuc
  fullname: Artuc, Metin
  organization: Berlin Institute of Health
– sequence: 4
  givenname: Sven
  surname: Guhl
  fullname: Guhl, Sven
  organization: Berlin Institute of Health
– sequence: 5
  givenname: Torsten
  surname: Zuberbier
  fullname: Zuberbier, Torsten
  organization: Berlin Institute of Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30091263$$D View this record in MEDLINE/PubMed
BookMark eNpdkUtuFDEQhi0URCYDCy6ALLHJppOy3bbTSzQkIdIgUAApO8s9Lg8e3O6h3R0yO47AGXOSOA9YUJt6ffpVqv-A7KU-ISGvGRyxEsd4446Y0Io_IzOmACpQXO6RGTSgKqVB7pODnDcATAstX5B9AdAwrsSM3Hy8PP98ecVpyDTh2o7hGuOOjnZY44iOtjv6ZXFGbXL0Ynn7-09Nx5660IUU8ne6zTi5voxtjDisw4rmMXRTLDJ9or2n-UdItLN5pCuMMdPSraY4TgO-JM-9jRlfPeU5-XZ2-nXxoVp-Or9YvFtWG1FLXgnW1CfMWs1qCUorobwF10ivXam8t7LVzkvLVCtb9Fr5VtaATtcKec2smJPDR93t0P-cMI-mC_n-GJuwn7LhcFKepSWHgr79D93005DKdYYzLpRoWElz8uaJmtoOndkOobPDzvz9aQGOH4FfIeLu356BuTfLFLPMg1nm9Or9QyHuAHHriTQ
ContentType Journal Article
Copyright 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Copyright_xml – notice: 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
– notice: 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
DBID NPM
7T5
H94
K9.
NAPCQ
7X8
DOI 10.1111/exd.13762
DatabaseName PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle PubMed
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList PubMed
AIDS and Cancer Research Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1600-0625
EndPage 1303
ExternalDocumentID 30091263
EXD13762
Genre shortCommunication
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Sixth EU Framework programme
  funderid: FOOD‐CT‐2004‐50637
– fundername: ECARF
– fundername: GA2LEN
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29G
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
CYRXZ
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
YUY
ZZTAW
~IA
~WT
AAMMB
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
NPM
7T5
H94
K9.
NAPCQ
O8X
7X8
ID FETCH-LOGICAL-j3452-319481aa7145067636fa0d95f7d6faffa5b7df5a16b5bef76fb540ed746e241a3
IEDL.DBID DRFUL
ISICitedReferencesCount 37
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000447846400016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0906-6705
1600-0625
IngestDate Fri Jul 11 13:56:16 EDT 2025
Sat Nov 29 14:40:49 EST 2025
Mon Jul 21 06:04:33 EDT 2025
Wed Jan 22 16:21:13 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords allergy
pseudo-allergy
mast cells
MRGPRX2
SCF
Language English
License 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-j3452-319481aa7145067636fa0d95f7d6faffa5b7df5a16b5bef76fb540ed746e241a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4500-7615
PMID 30091263
PQID 2123639112
PQPubID 2045157
PageCount 6
ParticipantIDs proquest_miscellaneous_2086257520
proquest_journals_2123639112
pubmed_primary_30091263
wiley_primary_10_1111_exd_13762_EXD13762
PublicationCentury 2000
PublicationDate November 2018
PublicationDateYYYYMMDD 2018-11-01
PublicationDate_xml – month: 11
  year: 2018
  text: November 2018
PublicationDecade 2010
PublicationPlace Denmark
PublicationPlace_xml – name: Denmark
– name: Chichester
PublicationTitle Experimental dermatology
PublicationTitleAlternate Exp Dermatol
PublicationYear 2018
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2009; 21
2017; 3
2017; 4
2015; 126
2016; 308
2017; 26
2011; 716
2008; 38
2006; 15
2011; 75
2006; 6
1035; 2011
2016; 126
2008; 300
2016; 16
2017; 136
2014; 23
2014; 134
2018; 19
2004; 75
2014; 5
2014; 507
2007; 217
2015; 519
2009; 124
2016; 138
2018; 73
2017; 18
2007; 3
2010; 91
2013; 191
2006; 126
2006; 349
2016; 25
2014; 10
2014; 123
2012; 8
2011; 286
References_xml – volume: 126
  start-page: 45
  year: 2015
  publication-title: Adv. Immunol.
– volume: 134
  start-page: 622
  year: 2014
  publication-title: J. Allergy Clin. Immunol.
– volume: 123
  start-page: e58
  year: 2014
  publication-title: Blood
– volume: 286
  start-page: 44739
  year: 2011
  publication-title: J. Biol. Chem.
– volume: 26
  start-page: 751
  year: 2017
  publication-title: Exp. Dermatol.
– volume: 126
  start-page: 1697
  year: 2006
  publication-title: J. Invest. Dermatol.
– volume: 26
  start-page: 659
  year: 2017
  publication-title: Exp. Dermatol.
– volume: 6
  start-page: 218
  year: 2006
  publication-title: Nat. Rev. Immunol.
– volume: 519
  start-page: 237
  year: 2015
  publication-title: Nature
– volume: 3
  start-page: 31
  year: 2007
  publication-title: Allergy Asthma Clin. Immunol.
– volume: 73
  start-page: 256
  year: 2018
  publication-title: Allergy
– volume: 217
  start-page: 141
  year: 2007
  publication-title: Immunol. Rev.
– volume: 136
  start-page: 123
  year: 2017
  publication-title: Adv. Immunol.
– volume: 3
  start-page: 17048
  year: 2017
  publication-title: Cell Death Discov.
– volume: 21
  start-page: 666
  year: 2009
  publication-title: Curr. Opin. Immunol.
– volume: 2011
  start-page: 12
  year: 1035
  publication-title: Nat. Immunol.
– volume: 8
  start-page: e1002619
  year: 2012
  publication-title: PLoS Pathog.
– volume: 5
  start-page: 453
  year: 2014
  publication-title: Front Immunol.
– volume: 25
  start-page: 434
  year: 2016
  publication-title: Exp. Dermatol.
– volume: 19
  start-page: 1
  year: 2018
  publication-title: Respir. Res.
– volume: 23
  start-page: 933
  year: 2014
  publication-title: Exp. Dermatol.
– volume: 75
  start-page: 382
  year: 2011
  publication-title: Biosci. Biotechnol. Biochem.
– volume: 124
  start-page: 639
  year: 2009
  publication-title: J. Allergy Clin. Immunol.
– volume: 349
  start-page: 1322
  year: 2006
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 308
  start-page: 665
  year: 2016
  publication-title: Arch. Dermatol. Res.
– volume: 10
  start-page: 977
  year: 2014
  publication-title: Exp. Rev. Clin. Immunol.
– volume: 138
  start-page: 700
  year: 2016
  publication-title: J. Allergy Clin. Immunol.
– volume: 126
  start-page: 3981
  year: 2016
  publication-title: J. Clin. Invest.
– volume: 16
  start-page: 20
  year: 2016
  publication-title: Curr. Allergy Asthma Rep.
– volume: 18
  start-page: E525
  year: 2017
  publication-title: Int. J. Mol. Sci.
– volume: 91
  start-page: 1256
  year: 2010
  publication-title: J. Gen. Virol.
– volume: 716
  start-page: 162
  year: 2011
  publication-title: Adv. Exp. Med. Biol.
– volume: 75
  start-page: 244
  year: 2004
  publication-title: J. Leukoc. Biol.
– volume: 4
  start-page: 170112
  year: 2017
  publication-title: Sci. Data
– volume: 15
  start-page: 530
  year: 2006
  publication-title: Exp. Dermatol.
– volume: 507
  start-page: 462
  year: 2014
  publication-title: Nature
– volume: 26
  start-page: 11
  year: 2017
  publication-title: Exp. Dermatol.
– volume: 300
  start-page: 461
  year: 2008
  publication-title: Arch. Dermatol. Res.
– volume: 191
  start-page: 345
  year: 2013
  publication-title: J. Immunol.
– volume: 26
  start-page: 1143
  year: 2017
  publication-title: Exp. Dermatol.
– volume: 38
  start-page: 4
  year: 2008
  publication-title: Clin. Exp. Allergy
– volume: 26
  start-page: 255
  year: 2017
  publication-title: Exp. Dermatol.
SSID ssj0017375
Score 2.3927724
Snippet MRGPRX2 was recently uncovered as the “missing link” in clinically relevant mast cell (MC) activation explaining previously puzzling phenomena. It is the...
MRGPRX2 was recently uncovered as the "missing link" in clinically relevant mast cell (MC) activation explaining previously puzzling phenomena. It is the...
SourceID proquest
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 1298
SubjectTerms Allergens
allergy
Cell activation
Cell culture
Degranulation
Exocytosis
Hypersensitivity
Mast cells
MRGPRX2
pseudo‐allergy
SCF
Skin
Title MRGPRX2 is negatively targeted by SCF and IL‐4 to diminish pseudo‐allergic stimulation of skin mast cells in culture
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fexd.13762
https://www.ncbi.nlm.nih.gov/pubmed/30091263
https://www.proquest.com/docview/2123639112
https://www.proquest.com/docview/2086257520
Volume 27
WOSCitedRecordID wos000447846400016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1600-0625
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017375
  issn: 0906-6705
  databaseCode: DRFUL
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3BbtQwEB2VLUJcoBQKC201SD1wCUri2M6KE2q7FKmtqoVKuUX22m4XaFJtdlF74xP4Rr6EsZONQOKA1JsTO5KlmTd-zthvAPbi2GotExcx66ZRJqcuyqeEK5ZrKaXyATELxSbk6WleFKOzNXi3ugvT6kP0P9w8MkK89gBXuvkD5PbGvE0IHhR_11PyWz6A9YPJ-Py4TyJIFnR24xFtmoWMeScs5A_y9B__i1j-zVPDQjN-fKcpbsCjjl_i-9YhnsCarTbhwUmXQX8KNyeTD2eTIsVZg5W9CLLf326xPRBuDepb_LQ_RlUZ_Hj868fPDBc1mllQILnE68YuTU2vfQWWOQVNpAhx1VUAw9ph83VW4ZVqFugzAg3SU6vtYZ_B-fjw8_5R1FVfiL6wjHslQy_kopRMMk5LmmDCqdiMuJOGWs4prqVxXCVCc22dFE4T-7NGZsISLVBsCwZVXdkXgFoKYZWUmucsE7EbpbnTLCf8G4opiR3C9soIZQehpvRrKtEn4oNDeN13k_P7-avK1ksa4zdkRDjTeAjPW-OV161KR8mIPSapYEN4E2zUd6y2PWSdMlinPCwOQuPl_w99BQ-JOuXtrcRtGCzmS7sD96ffF7Nmvgv3ZJHvdv74G9xh4vE
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NbxMxEB1VDaK98NWWBgoMEodettqNd-2NxAW1Da1Ioiq0Um4rO7YhtN2tsglKbvwEfiO_hLF3swKpByRu9torWZqZ5-evNwDvwtAoJSIbMGMnQSwmNkgnFFcsVUII6QAx9skmxHCYjsfdiw14v34LU-lDNBtuLjI8XrsAdxvSf0S5WeqjiOKDALgVkxuRf7dORr2rfnOKIJgX2g27tGrmIkxqZSF3k6f5-T5m-TdR9TNN7_H_jfEJPKoZJn6oXOIpbJj8GTwc1GfoO7AcjD5ejMYdnJaYmy9e-PtmhdWVcKNRrfDzcQ9lrvG8_-vHzxjnBeqp1yD5inelWeiCPrscLDOCTSSMuK1zgGFhsbye5ngryzm6M4ESqVape5hduOqdXh6fBXX-heAbixOnZeikXKQUUZzQpMYZtzLU3cQKTSVrZaKEtomMuEqUsYJbRfzPaBFzQ8RAsj3YzIvc7AMqwbmRQqgkZTEPbbeTWsVSQgBNqBKZNhysrZDVQVRmblYlAkWMsA1vm2Zyfzd-mZtiQX3ckowoZydsw_PKetldpdORMeKPUYezNhx6IzUN64UPWSfz1slOxye-8OLfu76BrbPLQT_rnw8_vYRtIlJp9UbxADbns4V5BQ8m3-fTcva6dsvfHB3l-Q
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Pb9MwFH6aOjRx4ddgFDZ4SDtwCUrqxE4lLmhdYKKrqsKk3iK7trcCS6qmRdttf8L-Rv4Snp00GhIHJG5O7EiWnt_3PufZ3wM4DEOjlIhswIydBbGY2SCdkV-xVAkhpAPE2BebEKNROp32x1vwfnMXptaHaH-4Oc_weO0c3Cy0vePl5kq_i8g_CIC3Y1dEpgPbg0l2NmyzCIJ5od2wT7tmLsKkURZyJ3naj__GLP8kqj7SZA__b46P4EHDMPFDvSQew5YpnsDOaZND34Wr08nH8WTaw3mFhTn3wt8_rrE-Em40qmv8cpShLDSeDH_d3Ma4KlHPvQbJBS4qs9YlvXY1WJYEm0gYcdnUAMPSYvV9XuClrFbocgIV0lOt7mGewll2_PXoU9DUXwi-sThxWoZOykVKEcUJBTXOuJWh7idWaGpZKxMltE1kxFWijBXcKuJ_RouYGyIGkj2DTlEW5jmgEpwbKYRKUhbz0PZ7qVUsJQTQhCqR6cL-xgp540RV7qIqEShihF1403bT8nfzl4Up1zTGbcmIcvbCLuzV1ssXtU5Hzog_Rj3OuvDWG6nt2Gx8yDq5t05-PB34xot_H_oadsaDLB-ejD6_hPvEo9L6iuI-dFbLtTmAe7Ofq3m1fNWsyt_NieV0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MRGPRX2+is+negatively+targeted+by+SCF+and+IL%E2%80%904+to+diminish+pseudo%E2%80%90allergic+stimulation+of+skin+mast+cells+in+culture&rft.jtitle=Experimental+dermatology&rft.au=Babina%2C+Magda&rft.au=Wang%2C+Zhao&rft.au=Artuc%2C+Metin&rft.au=Guhl%2C+Sven&rft.date=2018-11-01&rft.issn=0906-6705&rft.eissn=1600-0625&rft.volume=27&rft.issue=11&rft.spage=1298&rft.epage=1303&rft_id=info:doi/10.1111%2Fexd.13762&rft.externalDBID=10.1111%252Fexd.13762&rft.externalDocID=EXD13762
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0906-6705&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0906-6705&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0906-6705&client=summon